Componenta (CTH1V) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Jul, 2025Executive summary
Net sales for January–June 2025 reached EUR 59.7 million, up 19.4% year-over-year.
EBITDA improved to EUR 5.0 million from EUR 1.9 million in the same period last year.
Operating profit was EUR 2.3 million, compared to a loss of EUR -0.8 million year-over-year.
Order book at period end was EUR 14.2 million, up from EUR 10.8 million, supported by acquisitions and new sales.
Cash flow from operating activities increased to EUR 3.1 million from EUR 1.8 million.
Financial highlights
Net sales grew 19% year-over-year for the half-year period, reaching EUR 59.7 million.
Adjusted EBITDA was EUR 5.0 million, up from EUR 1.9 million.
Cash and cash equivalents at period end were EUR 9.1 million, up from EUR 6.5 million.
Net interest-bearing debt reduced to EUR 4.1 million (EUR 8.9 million), net gearing at 15.0%.
Unused revolving credit facilities totaled EUR 5.0 million, with an undrawn capex/investment loan of EUR 2 million.
Outlook and guidance
Guidance for 2025 remains unchanged: net sales and adjusted EBITDA expected to improve from 2024.
Long-term targets: net sales to exceed EUR 150 million organically by 2027, EBIT margin above 5%.
Plan to distribute one-third of annual net profit as dividends starting from 2025.
Profit accumulation expected to be concentrated in Q4 due to seasonal factors.
Acquisitions targeted to further boost sales growth and profitability.
Latest events from Componenta
- Net sales and profitability surged, with strong cash and order book growth supporting a positive outlook.CTH1V
Q4 20256 Mar 2026 - Sales and EBITDA surged, order book grew, and liquidity stayed stable amid uncertainty.CTH1V
Q3 202530 Oct 2025 - Net sales and EBITDA fell, but Q3 improved and acquisitions support future growth.CTH1V
Q3 202413 Jun 2025 - Sales and profit fell, but new contracts and acquisitions signal recovery in H2 2024.CTH1V
Q2 202413 Jun 2025 - Sales and profitability surged, with strong liquidity and a positive outlook for 2025.CTH1V
Q1 20255 Jun 2025 - EBITDA and cash flow surged despite lower net sales, with a strong order book and positive outlook.CTH1V
Q4 20245 Jun 2025